Post-Market Study of the Argus® II Retinal Prosthesis System - France

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

November 20, 2014

Primary Completion Date

March 20, 2018

Study Completion Date

November 20, 2018

Conditions
Retinitis Pigmentosa
Interventions
DEVICE

Argus II Retinal Prosthesis System

The Argus II System is designed to provide visual function to individuals with severe to profound vision loss due to outer retinal degeneration. It consists of implanted and external components. The implant is an epiretinal prosthesis that is surgically implanted in and around the eye. The external equipment includes glasses and a video processing unit (VPU). The glasses include a miniature video camera, which captures video images, and a coil that sends data and stimulation commands to the implant. The VPU converts the video images into stimulation commands and is body-worn. The Argus II System operates by converting video images into electrical energy that activates retinal cells, delivering the signal through the optic nerve to the brain where it is perceived as light.

Trial Locations (3)

33000

Centre Hospitalier Universitaire de Bordeaux, Bordeaux

67091

Hôpitaux Universitaires de Strasbourg, Strasbourg

75571

Centre hospitalier National d'Ophtalmologie des Quinze-Vingts, Paris

All Listed Sponsors
lead

Second Sight Medical Products

INDUSTRY

NCT02303288 - Post-Market Study of the Argus® II Retinal Prosthesis System - France | Biotech Hunter | Biotech Hunter